Australia markets open in 46 minutes

Zelira Therapeutics Limited (ZLD.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.6950+0.0150 (+2.21%)
At close: 03:35PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
301.121
301.121
1,541
432.568
-
Cost of revenue
362.56
362.56
939.054
228.222
-
Gross profit
-61.439
-61.439
601.57
204.346
-
Operating expenses
Research development
1,336
1,336
-
2,081
-
Selling general and administrative
3,062
3,062
6,078
4,490
1,974
Total operating expenses
7,202
7,202
14,247
10,196
7,937
Operating income or loss
-7,263
-7,263
-13,645
-9,991
-7,937
Interest expense
12.344
76.661
53.848
42.627
12.344
Total other income/expenses net
1,071
1,071
1,275
1,484
925.491
Income before tax
-6,269
-6,269
-12,414
-8,549
-7,015
Income tax expense
0
0
0
0
0
Income from continuing operations
-6,269
-6,269
-12,414
-8,549
-7,015
Net income
-5,573
-5,573
-11,945
-8,549
-7,015
Net income available to common shareholders
-5,573
-5,573
-11,945
-8,549
-7,015
Basic EPS
-0.55
-0.55
-1.54
-1.28
-1.45
Diluted EPS
-0.55
-0.55
-1.54
-1.28
-1.45
Basic average shares
10,068
10,068
8,042
6,633
4,848
Diluted average shares
10,068
10,068
8,042
6,633
4,848